• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New research shows no link between COVID-19 vaccination during pregnancy and higher risk of preterm birth or stillbirth

Bioengineer by Bioengineer
August 29, 2022
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Vaccination against COVID-19 during pregnancy is not associated with a higher risk of preterm birth, small for gestational age at birth, or stillbirth, concludes a new population based retrospective cohort study led by the CHEO Research Institute and the University of Ottawa’s Faculty of Medicine.

New research shows no link between COVID-19 vaccination during pregnancy and higher risk of preterm birth or stillbirth

Credit: University of Ottawa

Vaccination against COVID-19 during pregnancy is not associated with a higher risk of preterm birth, small for gestational age at birth, or stillbirth, concludes a new population based retrospective cohort study led by the CHEO Research Institute and the University of Ottawa’s Faculty of Medicine.

These findings, published recently in The BMJnorth_eastexternal link, can help inform evidence based decision making about the risks and benefits of COVID-19 vaccination during pregnancy.

“Our study found no evidence of increased risk of preterm birth, very preterm birth, small-for gestational-age at birth, or still birth following COVID-19 vaccination during pregnancy. The results of this study provide further evidence for care providers and pregnant people about the safety of COVID-19 vaccination during pregnancy,” said lead author Dr. Deshayne Fell, Scientist at the CHEO Research Institute and Associate Professor in the University of Ottawa’s Faculty of Medicine.

SARS-CoV-2 infection during pregnancy has been associated with higher risks of complications, including admission to hospital and death for pregnant individuals, as well as preterm birth and stillbirth. COVID-19 vaccination during pregnancy has been shown to be effective against COVID-19 in pregnant individuals as well as their newborns, but evidence about pregnancy outcomes after COVID-19 vaccination during pregnancy from large studies is limited.

In a project supported by the Public Health Agency of Canada through the Vaccine Surveillance Reference Group and the COVID-19 Immunity Task Force, researchers set out to assess the risk of preterm birth, small for gestational age at birth, and stillbirth after COVID-19 vaccination during pregnancy.

They used the BORN Ontario birth registry, the provincial birth registry based out of CHEO, to identify all liveborn and stillborn infants with a gestational age of at least 20 weeks or birth weight of at least 500g in Ontario, Canada between May 1 and Dec. 31, 2021. This information was then linked to the COVaxON, the province’s COVID-19 immunization database.

A wide range of potentially influential factors were taken into account, including the mother’s age at delivery, pre-pregnancy body mass index, reported smoking or substance use during pregnancy, pre-existing health conditions, number of previous live births and stillbirths, area of residence and income.

Of 85,162 births, 43,099 occurred in individuals who received one dose or more of a COVID-19 vaccine during pregnancy – 42, 979 (99.7%) received an mRNA vaccine, mainly Pfizer-BioNTech or Moderna. (See Figure 1)

The study found that vaccination during pregnancy was not associated with any increased risk of overall preterm birth (6.5% among vaccinated v 6.9% among unvaccinated), spontaneous preterm birth (3.7% v 4.4%), or very preterm birth (0.59% v 0.89%). No increase was found in risk of small for gestational age at birth (9.1% v 9.2%) or stillbirth (0.25% v 0.44%).

Findings were similar irrespective of what stage (trimester) of pregnancy vaccination was given, number of doses received during pregnancy, or which mRNA vaccine product was received. There are still some important unanswered questions in need of future research, such as assessing COVID-19 vaccination before pregnancy or around the time of conception and assessment of non-mRNA vaccines used during pregnancy.

Researchers noted “Future studies to assess similar outcomes after immunisation with nonmRNA COVID-19 vaccine types during pregnancy should be a research priority.”

Reference: Deshayne B Fell; Sheryll Dimanlig-Cruz; Annette K Regan; Shelley D Dougan et al. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study. The BMJ. Published Aug. 17, 2022. DOI: https://doi.org/10.1136/bmj-2022-071416 Original version of the news release comes from the BMJ.



Journal

The BMJ

DOI

10.1136/bmj-2022-071416

Method of Research

Data/statistical analysis

Subject of Research

People

Article Title

Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study

Article Publication Date

17-Aug-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Quinoline Triazoles: Antimicrobial Strategies Against Biofilms

August 27, 2025

Exploring Aged Garlic Extract’s Effects on Oral Bacteria

August 27, 2025

Blood and Fluid Signatures Predict IVF Embryo Success

August 27, 2025

Enhancing 3D-Printed Biphasic Scaffolds with Hourglass Design

August 27, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nucleotides: Key Nutrients for Healthy Laying Hens

68Ga-FAPI-04 PET/CT vs. CECT for Peritoneal Metastases

Quinoline Triazoles: Antimicrobial Strategies Against Biofilms

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.